Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Akin Gump
- Alston & Bird
- Andrews & Thornton
- ArentFox Schiff
- Arnold & Porter
- ASK LLP
- Ballard Spahr
- Barack Ferrazzano
- BatesCarey
- Bentley & Bruning
- Bialson Bergen
- Bielli & Klauder
- Binder & Schwartz
- Blank Rome
- Blitman & King
- Brown & Connery
- Brown Rudnick
- Caplin & Drysdale
- Carter Ledyard
- Cleary Gottlieb
- Clifford Law Offices
- Consovoy McCarthy
- Cozen O'Connor
- Cronin Fried
- Crowell & Moring
- Cuneo Gilbert
- Davis Polk
- Debevoise & Plimpton
- Dechert LLP
- Doster Ullom
- Duane Morris
- Faegre Drinker
- Foley & Lardner
- FrankGecker
- Frost Brown
- Gage Spencer & Fleming
- Gertz & Rosen
- Gilbert LLP
- Godfrey & Kahn
- Goodwin Procter
- Hagens Berman
- Haug Partners
- Henrichsen Law Group
- Himes Petrarca
- Hobbs Straus
- Hughes Socol
- Hurwitz Fine
- Ifrah Law
- Jenner & Block
- Jones Day
- Joseph Hage Aaronson
- Katsky Korins
- Keller Postman
- Keller Rohrback
- King & Spalding
- Kirkland & Ellis
- Klehr Harrison
- Kleinberg Kaplan
- Kobre & Kim
- Kramer Levin
- Latham & Watkins
- Law Office of Nhan Nguyen
- Lerner Arnold
- Levenfeld Pearlstein
- Lite DePalma
- Locke Lord
- Loeb & Loeb
- Lowe Stein
- Lowey Dannenberg
- MacElree Harvey
- Marcus & Shapira
- Marino Tortorella
- Mayer Brown
- McElroy Deutsch
- McGrail & Bensinger
- Mehri & Skalet
- Miller Nash LLP
- Miller Shah LLP
- Mintz Levin
- MoloLamken
- Morgan Lewis
- Motley Rice
- Napoli Shkolnik
- O'Brien Belland
- O'Melveny & Myers
- Pachulski Stang
- Phillips Lytle
- Pillsbury Winthrop
- Porteous Hainkel
- Porter Hedges
- Porzio Bromberg
- Potter Anderson
- Pullman & Comley
- Reed Smith
- Robins Kaplan
- Rothstein Mandell
- Saul Ewing
- Schulte Roth
- Seward & Kissel
- Shafferman & Feldman
- Sherrard Roe
- Shipman & Goodwin
- Shook Hardy
- Simpson Thacher & Bartlett LLP
- Skadden Arps
- Slevin & Hart
- Spangenberg Shibley
- Squire Patton
- Stevens & Lee
- Stutzman Bromberg
- Taft Stettinius
- Tarter Krinsky
- Tate Law Group LLC
- Teitelbaum Law Group
- Terrell Hogan
- The Cooper Law Firm
- UB Greensfelder
- Wachtell Lipton
- Waldrep Wall
- White & Case
- White Coleman & Associates
- Wilk Auslander
- Williams Mullen
- Willkie Farr
- WilmerHale
Companies
- Alaska Native Tribal Health Consortium
- Aleutian Pribilof Islands Association Inc.
- Allergan PLC
- American Federation of Labor & Congress of Industrial Organizations
- Amneal Pharmaceuticals Inc.
- Anda Inc.
- Apria Healthcare Group
- Arcadia Consumer Healthcare
- ASM Capital LP
- Avrio Health LP
- AXA XL Ltd.
- Bausch Health Cos. Inc.
- Blue Cross Blue Shield Association
- Bristol-Myers Squibb Co.
- Cardinal Health Inc.
- Cencora Inc.
- Collegium Pharmaceutical Inc.
- CVS Health Corp.
- DuPont de Nemours Inc.
- Endo International PLC
- Express Scripts Holding Co.
- Giant Eagle Inc.
- Hain Capital Group LLC
- Henry Schein Inc.
- Hikma Pharmaceuticals PLC
- Houlihan Lokey Inc.
- Impax Laboratories, Inc.
- International Union Of Operating Engineers
- Ironshore Inc.
- Jefferies Financial Group Inc.
- Johnson & Johnson
- Kodiak Area Native Association
- KVK Tech Inc.
- Liberty Mutual Insurance Group
- Loblaw Cos.
- McKesson Corp.
- Noramco Inc.
- Old Republic Insurance Co.
- Omnicare Inc.
- Oracle Corp.
- PRA Health Sciences Inc.
- Province LLC
- Purdue Pharma LP
- Ranbaxy
- SAP AG
- Sun Pharmaceutical Industries Ltd.
- Teamsters Local 456
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- Thermo Fisher Scientific Inc.
- TR Capital Management LLC
- Tucson Medical Center
- United Food & Commercial Workers International Union
- United Parcel Service Inc.
- Viatris Inc.
- Walmart Inc.
Government Agencies
- Borough of Paramus, New Jersey
- City of Bayonne, New Jersey
- Commonwealth of Massachusetts
- Hopi Tribe
- Jamestown S'Klallam Tribe
- Missouri Department of Revenue
- New York Department of Financial Services
- Nez Perce Tribe
- Northwestern Band of the Shoshone Nation
- Pala Band of Mission Indians
- Pension Benefit Guaranty Corp.
- Port Gamble S'Klallam Tribe
- Seldovia Village Tribe
- State of Indiana
- State of Nevada
- St. Regis Mohawk Tribe
- Suquamish Tribe
- Tennessee Attorney General's Office
- Town of Babylon, New York
- Town of Brookhaven, New York
- Town of Hempstead, New York
- Town of Ramapo, New York
- Washington State Department of Revenue
Sectors & Industries:
-
May 20, 2021
Purdue Says It May Have To Push Back Ch. 11 Schedule
Drugmaker Purdue Pharma told a New York bankruptcy judge Thursday that it may not be able to keep to the schedule it set for its Chapter 11 case, saying it is hitting some "intractable" issues as it negotiates the terms of its restructuring.
-
May 12, 2021
Purdue's Ch. 11 Confirmation Hearing Set For August
A New York bankruptcy judge on Wednesday approved a motion setting an August date for Purdue Pharma's Chapter 11 plan confirmation hearing, assuming the drugmaker's plan disclosure statement is approved next week.
-
May 07, 2021
Purdue Asks For Another Month's Hold On Opioid Suits
Purdue Pharma is asking a New York bankruptcy judge for another 27-day extension of an injunction freezing opioid suits against the company and its owners, saying it needs more time to ensure it gets court approval for its Chapter 11 plan disclosures.
-
April 27, 2021
Newborn Opioid Victim Group Says Purdue Docs Lack Info
A group representing the interests of victims of neonatal abstinence syndrome in the bankruptcy case of opioid maker Purdue Pharma told a New York judge late Monday that the debtor's Chapter 11 plan documents don't provide enough information about their treatment.
-
April 08, 2021
Purdue Wants Another Month's Reprieve From Opioid Suits
Purdue Pharma has asked a New York bankruptcy judge for another month of relief from lawsuits over its opioid sales, saying negotiations on the final form of its Chapter 11 plan are at a "critical stage."
-
April 06, 2021
Purdue Judge Wary Of Changing Reasons For Ch. 11 Probe
A New York bankruptcy judge has asked a committee representing children allegedly injured by Purdue Pharma-made opioids to clarify why they are seeking a probe into OxyContin toxicology studies, saying its reasons have shifted since they first asked.
-
March 24, 2021
Purdue, Sackler Opioid Suits Paused For Another Month
A New York bankruptcy judge on Wednesday granted Purdue Pharma and its former owners another month's relief from suits over Purdue's opioid sales, saying the continued pause will protect efforts to work out the details of the company's Chapter 11 plan.
-
March 22, 2021
States Say Time Has Come To Let Sackler Suits Proceed
A group of states asked a New York bankruptcy judge Friday to deny Purdue Pharma's latest request to extend the injunction pausing their suits against the Sackler family, saying allowing their claims to go forward will create a better Chapter 11 plan.
-
March 16, 2021
Unhappy AGs Have Options In Latest Purdue Ch. 11 Plan
The worst fears of state attorneys general materialized on Tuesday when Purdue Pharma LP and the Sackler family revealed the details of the company's Chapter 11 bankruptcy plan, with many states immediately declaring their "disappointment" about accountability and remedies for the deadliest drug crisis in the nation's history.
-
March 16, 2021
Purdue's Ch. 11 Plan Hangs On Sackler Liability Question
The viability of Purdue Pharma's much anticipated Chapter 11 plan hangs on whether creditors are willing to release the Sackler family from what could be heaps of liability in exchange for their $4.5 billion in contributions that would fund creditor recoveries and opioid abatement programs, experts told Law360.